印度的唐氏综合征筛查：我们做到了吗？
Down Syndrome Screening in India: Are We There Yet?
作者信息
Manikandan K, Seshadri Suresh
机构信息
Department of Fetal Medicine, Mediscan Systems, 197, Dr Natesan Road, Mylapore, Chennai, 600 004 India.
Fetal Care Research Foundation, Chennai, India.
出版信息
J Obstet Gynaecol India. 2017 Dec;67(6):393-399. doi: 10.1007/s13224-017-1042-z. Epub 2017 Aug 17.
Abstract
Down syndrome is the most common cause of intellectual disability among live born children and is amenable to prenatal detection. Screening for Down syndrome on a population basis requires a thorough understanding of the principles involved in the screening tests. We discuss the rationale behind the commonly available screening tests and the Indian scenario in this setting.
摘要
唐氏综合征是活产儿中智力残疾最常见的病因，且可通过产前检测发现。基于人群进行唐氏综合征筛查需要深入理解筛查测试所涉及的原理。我们在此讨论常用筛查测试背后的基本原理以及印度在这方面的情况。
相似文献
1
Down Syndrome Screening in India: Are We There Yet?
J Obstet Gynaecol India. 2017 Dec;67(6):393-399. doi: 10.1007/s13224-017-1042-z. Epub 2017 Aug 17.
2
Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario.
Indian J Med Res. 2017 Dec;146(6):689-699. doi: 10.4103/ijmr.IJMR_1788_15.
3
Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.
Clin Chim Acta. 2002 Sep;323(1-2):1-16. doi: 10.1016/s0009-8981(02)00186-9.
4
From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Taiwan J Obstet Gynecol. 2013 Dec;52(4):470-4. doi: 10.1016/j.tjog.2013.10.003.
5
Antenatal screening for Down syndrome with special considerations in the Puerto Rican population.
P R Health Sci J. 2011 Dec;30(4):206-10.
6
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Obstet Gynecol. 2007 Sep;110(3):651-7. doi: 10.1097/01.AOG.0000278570.76392.a6.
7
Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand.
Int J Gynaecol Obstet. 2017 Nov;139(2):217-221. doi: 10.1002/ijgo.12290. Epub 2017 Aug 14.
8
The quadruple test for Down syndrome screening in pregnant women of advanced maternal age.
Arch Gynecol Obstet. 2012 Mar;285(3):629-33. doi: 10.1007/s00404-011-2052-1. Epub 2011 Aug 12.
9
[Down syndrome screening in France: the worst consensus].
J Gynecol Obstet Biol Reprod (Paris). 2007 Apr;36(2):95-103. doi: 10.1016/j.jgyn.2006.12.021. Epub 2007 Feb 6.
10
Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
Am J Obstet Gynecol. 2007 Apr;196(4):315.e1-7; discussion 285-6. doi: 10.1016/j.ajog.2007.01.037.
引用本文的文献
1
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions.
Diagnostics (Basel). 2023 Aug 2;13(15):2570. doi: 10.3390/diagnostics13152570.
2
Correlates of knowledge of genetic diseases and congenital anomalies among pregnant women attending antenatal clinics in Lagos, South-West Nigeria.
Pan Afr Med J. 2021 Mar 28;38:310. doi: 10.11604/pamj.2021.38.310.26636. eCollection 2021.
3
Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.
PLoS One. 2021 May 13;16(5):e0251381. doi: 10.1371/journal.pone.0251381. eCollection 2021.
4
Comment on Two Recent Invited Mini-reviews.
J Obstet Gynaecol India. 2019 Apr;69(2):194-195. doi: 10.1007/s13224-018-1132-6. Epub 2018 May 12.
本文引用的文献
1
Down syndrome in tribal population in India: A field observation.
J Neurosci Rural Pract. 2016 Jan-Mar;7(1):40-3. doi: 10.4103/0976-3147.172167.
2
Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
Ultrasound Obstet Gynecol. 2016 Jan;47(1):38-44. doi: 10.1002/uog.15820.
3
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
Ultrasound Obstet Gynecol. 2015 Jan;45(1):16-26. doi: 10.1002/uog.14636.
4
Unity in diversity: an overview of the genomic anthropology of India.
Ann Hum Biol. 2014 Jul-Aug;41(4):287-99. doi: 10.3109/03014460.2014.922615.
5
Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India.
Prenat Diagn. 2012 Dec;32(12):1192-6. doi: 10.1002/pd.3984. Epub 2012 Oct 11.
6
Incidence of down syndrome: Hypotheses and reality.
Indian J Hum Genet. 2011 Sep;17(3):117-9. doi: 10.4103/0971-6866.92080.
7
Cytogenetic analysis of 1572 cases of Down syndrome: a report of double aneuploidy and novel findings 47,XY, t(14;21)(q13;q22.3)mat,+21 and 45,XX,t(14;21) in an Indian population.
Genet Test Mol Biomarkers. 2010 Aug;14(4):499-504. doi: 10.1089/gtmb.2009.0167.
8
The relative effects of paternal and maternal age in mongolism. 1933.
J Genet. 2009 Apr;88(1):9-14. doi: 10.1007/s12041-009-0002-5.
9
Cytogenetic analysis of Down syndrome in Gujarat.
Indian Pediatr. 2007 Oct;44(10):774-7.
10
The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.
Matern Child Health J. 2008 Sep;12(5):620-3. doi: 10.1007/s10995-007-0272-6. Epub 2007 Aug 22.
Zotero 插件